Skip to main content

Pharmacovigilance

  • Work as Senior Pharmacovigilance Specialist in UnitedHealth Group

    At UnitedHealth Group, our mission is to help people live healthier lives. To achieve this goal, we are focused on building a modern, adaptable, innovative and inclusive system of health care services.
    Our scale and potential to improve health makes us one of the most visible stewards of America’s vast health care system. Entrusted with both important resources and responsibilities, we are involved on a daily basis in decision-making that has life-changing consequences for millions of Americans.

  • Work in Medical Writing - Pharmacovigilance @ J. B. Chemicals & Pharmaceuticals Ltd.

    J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL), known to many as Unique Pharmaceutical Laboratories is one of India's leading global pharmaceutical companies. The company manufactures and markets a wide range of pharmaceutical formulations.

    Post:  Medical Writing - Pharmacovigilance

    [adsense:336x280:8701650588]

  • Career opportunity in Novartis for the post of Pharmacovigilance Data Manager

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

  • Recession hit West storms into India for clinical research, pharmacovigilance next growth path for CROs

     India’s clinical research organizations (CROs) are set for exponential growth going by the number of assignments which are coming in here. The global economic slowdown which has seriously impacted western world has benefited the Indian clinical research industry. Scores of assignments are pouring in to conduct clinical trials, pharmacovigilance studies and data management works.

  • Several drugs to come under regulatory scanner as national pharmacovigilance programme to begin in April

    Two H1N1 drugs - oseltamivir and zanamavir, the controversial sub-fertility drug letrozole, popular non-steroidal anti-inflammatory drug nimesulide, decongestant drug phenylpropanolamine (PPA), antibiotic drug gatifloxacine, chronic constipation drug tegaserod, type-2 diabetes drug pioglitazone and rosiglitazone have been selected for the first phase of national pharmacovigilance programme which will begin in select 40 medical colleges across the country from April this year.

Subscribe to Pharmacovigilance